Immunitas Therapeutics and Lonza Announce Manufacturing Agreement to Rapidly Advance Lead Program to the Clinic April 16, 2021
Bicycle Therapeutics Announces Significant Progress Across Multiple Therapeutic Programs Beyond Oncology March 31, 2021
Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics March 30, 2021
Lassen Therapeutics Announces Collaboration with Cedars Sinai Medical Center to Study the Role of IL-11 Signaling and Inhibition in Preclinical Models of Lung Fibrosis March 25, 2021
XyloCor Therapeutics Completes Oversubscribed $41.9 Million Series A Financing To Advance Novel Gene Therapy Pipeline For Coronary Artery Disease March 25, 2021
